Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis-Reference-Cited by-同舟云学术

Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis

Published:1997-09 Issue:2 Volume:150 Page:103-113
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Hunter Samuel F,Miller David J,Rodriguez Moses

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference38 articles.

1. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes;Asakura;J. Neurosci. Res.,1996

2. A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens;Asakura;J. Neuroimmunol.,1996

3. The natural autoantibodies system: between hypotheses and facts;Avrameas;Mol. Immunol.,1993

4. Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids;Bansal;Proc. Natl. Acad. Sci. USA,1989

5. Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid;Bansal;J. Neurosci. Res.,1988

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Signaling Pathway Downstream of RIG-I/MAVS in the CNS Stimulates Production of Endogenous Type I IFN and Suppresses EAE;International Journal of Molecular Sciences;2022-09-25

2. Innate Signaling in the CNS Prevents Demyelination in a Focal EAE Model;Frontiers in Neuroscience;2021-06-03

3. A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?;Expert Opinion on Biological Therapy;2018-02-25

4. Autoantibodies and their potential roles in diseases of the nervous system;Clinical and Experimental Neuroimmunology;2015-11

5. Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice;Nucleic Acid Therapeutics;2015-02